Benefits and Harms of Omalizumab Treatment in Adolescent and Adult Patients With Chronic Idiopathic (Spontaneous) Urticaria: A Meta-analysis of “Real-world” Evidence

IMPORTANCE: Omalizumab is indicated for the management of chronic idiopathic urticaria (CIU) (also known as chronic spontaneous urticaria) in adolescents and adults with persistent hives not controlled with antihistamines. The effectiveness of omalizumab in the real-world management of CIU is largel...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:JAMA Dermatol
Autores principales: Tharp, Michael D., Bernstein, Jonathan A., Kavati, Abhishek, Ortiz, Benjamin, MacDonald, Karen, Denhaerynck, Kris, Abraham, Ivo, Lee, Christopher S.
Formato: Artigo
Lenguaje:Inglês
Publicado: American Medical Association 2018
Materias:
Original Investigation
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC6439579/
https://ncbi.nlm.nih.gov/pubmed/30427977
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamadermatol.2018.3447
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares